Servier Pharmaceuticals is a privately held company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.
Our patients are fundamental to our culture. We are committed to engaging with patients, caregivers, families and patient organizations to ensure their voices are heard in every initiative.
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patients.
Collaborations are a core part of our business. We are seeking partners who share our values and commitment to improving the lives of the patients, caregivers and families we serve.
Our responsibility is to help make the world a better place for our patients and their families. We are committed to creating a brighter future for all of us.
We continue to build our treatment portfolio with a current focus on oncology within the United States. Globally, our pipeline includes a robust portfolio of treatments for various therapeutic areas.
Learn MoreWe invest in innovative research and development through our own development or partnerships to best address the unmet needs of patients.
Learn More
© Servier Pharmaceuticals LLC. Servier and Servier logo are trademarks LES LABORATOIRES SERVIER. ONCASPAR and PIXUVRI are registered trademarks and ASPARLAS is a registered trademark of Servier IP UK LTD, a wholly owned, indirect subsidiary of LES LABORATOIRES SERVIER. 2021
By clicking on a link, you may enter a different part of this website, or a website outside of www.servier.us. Websites administered by third parties are governed by their own Legal and Privacy Policies. Servier assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third-party sites. Additionally, the presence of this link does not imply the third-party site's endorsement of Servier or this website.
You are about to leave www.servier.us and be redirected to another Servier domain.
